STOCK TITAN

Advent Technologies Holdng Inc SEC Filings

ADN NASDAQ

Welcome to our dedicated page for Advent Technologies Holdng SEC filings (Ticker: ADN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

The Advent Technologies Holdings, Inc. (ADN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. These documents explain how Advent describes its fuel cell and hydrogen technology business, its capital structure, governance, and key risks.

Through Advent’s annual reports on Form 10-K and quarterly reports on Form 10-Q, readers can review management’s discussion of operations, financial statements, and information about its HT-PEM fuel cell systems, Membrane Electrode Assembly (MEA) technology, and related markets. When a report is delayed, notifications such as Form 12b-25 (NT 10-Q) describe the reasons for late filing and the expected timing.

Current reports on Form 8-K document material events, including equity purchase agreements and loans with Hudson Global Ventures LLC, pre-funded warrants, orders and contracts, and communications from The Nasdaq Stock Market LLC regarding listing compliance and delisting proceedings. One 8-K filed in October 2025 reports Nasdaq’s determination to commence delisting and suspend trading of Advent’s common stock and warrants, and notes the expectation that ADN and ADNWW will trade on the OTC market.

Proxy materials such as the DEF 14A detail proposals for director elections, auditor ratification, incentive plan amendments, and advisory votes on executive compensation and its frequency. Registration statements like the S-1 describe offerings of common stock, use of proceeds, risk factors, and the terms of equity purchase arrangements.

On Stock Titan, these filings are paired with AI-powered summaries that highlight key points from lengthy documents, helping readers quickly identify items such as capital-raising terms, governance changes, and listing status disclosures. Users can also review Form 4 and other insider transaction reports when available, to see how officers, directors, and significant shareholders transact in ADN securities over time.

Rhea-AI Summary

Advent Technologies Holdings, Inc. filed an 8-K reporting the entry into a material definitive agreement and an unregistered sale of equity securities. The filing lists a Registration Rights Agreement dated August 14, 2025 between the company and Hudson as an exhibit. The document identifies the event categories but provides no transaction economics, share counts, or pricing in the excerpt provided. The form is signed on behalf of the company by Gary Herman, Chief Executive Officer.

The disclosure signals a financing or equity transfer tied to registration rights for the purchaser, which can affect share liquidity and potential dilution depending on the omitted terms. Key transactional details required to judge material financial impact (amounts, number of shares, use of proceeds, and effective dates beyond the exhibit date) are not present in the supplied text.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.02%
Tags
current report
-
Rhea-AI Summary

Advent Technologies Holdings, Inc. reported weak interim results with cash of $75 thousand and total assets of $6.69 million as of June 30, 2025. Revenue for the quarter was $99 thousand (down from $654 thousand a year earlier) and the company recorded a net loss of $3.797 million for the three months and $7.071 million for the six months ended June 30, 2025.

The balance sheet shows total liabilities of $36.112 million and a stockholders' deficit of $29.422 million, including a negative net working capital position of $27.8 million. Management discloses substantial doubt about the company’s ability to continue as a going concern and outlines reliance on additional equity or debt financing, recent high-cost short-term loans, a settlement with F.E.R. for approximately €5.37 million and the bankruptcy and liquidation of its Danish subsidiary, presented as discontinued operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
59.18%
Tags
quarterly report
-
Rhea-AI Summary

Advent Technologies Holdings, Inc. filed a Form 8-K reporting that its wholly-owned subsidiary, Advent Technologies, Inc., finalized a partially exclusive field-of-use patent license with TRIAD National Security for the Ion Pair technology originally developed at Los Alamos National Laboratory. The Agreement, which supersedes a prior license between the parties, grants Advent Sub exclusivity in the marine, aviation, and portable power fields while Advent Sub retains non-exclusive rights in all other fields.

The filing attaches the press release as Exhibit 99.1 and a cover page interactive data file as Exhibit 104, and is signed by CEO Gary Herman on August 12, 2025. The document does not disclose financial terms, duration, or other commercial details of the Agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
59.18%
Tags
current report
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report

FAQ

What is the current stock price of Advent Technologies Holdng (ADN)?

The current stock price of Advent Technologies Holdng (ADN) is $0.9185 as of October 30, 2025.

What is the market cap of Advent Technologies Holdng (ADN)?

The market cap of Advent Technologies Holdng (ADN) is approximately 3.0M.

ADN Rankings

ADN Stock Data

3.02M
2.97M
Electrical Equipment & Parts
Miscellaneous Electrical Machinery, Equipment & Supplies
Link
United States
BOSTON

ADN RSS Feed